| Literature DB >> 26965621 |
Paolo Zanoni1, Sumeet A Khetarpal1, Daniel B Larach1, William F Hancock-Cerutti2, John S Millar1, Marina Cuchel1, Stephanie DerOhannessian1, Anatol Kontush3, Praveen Surendran4, Danish Saleheen5, Stella Trompet6, J Wouter Jukema7, Anton De Craen8, Panos Deloukas9, Naveed Sattar10, Ian Ford11, Chris Packard12, Abdullah al Shafi Majumder13, Dewan S Alam14, Emanuele Di Angelantonio4, Goncalo Abecasis15, Rajiv Chowdhury4, Jeanette Erdmann16, Børge G Nordestgaard17, Sune F Nielsen17, Anne Tybjærg-Hansen18, Ruth Frikke Schmidt19, Kari Kuulasmaa20, Dajiang J Liu21, Markus Perola22, Stefan Blankenberg23, Veikko Salomaa20, Satu Männistö20, Philippe Amouyel24, Dominique Arveiler25, Jean Ferrieres26, Martina Müller-Nurasyid27, Marco Ferrario28, Frank Kee29, Cristen J Willer30, Nilesh Samani31, Heribert Schunkert32, Adam S Butterworth4, Joanna M M Howson4, Gina M Peloso33, Nathan O Stitziel34, John Danesh35, Sekar Kathiresan33, Daniel J Rader36.
Abstract
Scavenger receptor BI (SR-BI) is the major receptor for high-density lipoprotein (HDL) cholesterol (HDL-C). In humans, high amounts of HDL-C in plasma are associated with a lower risk of coronary heart disease (CHD). Mice that have depleted Scarb1 (SR-BI knockout mice) have markedly elevated HDL-C levels but, paradoxically, increased atherosclerosis. The impact of SR-BI on HDL metabolism and CHD risk in humans remains unclear. Through targeted sequencing of coding regions of lipid-modifying genes in 328 individuals with extremely high plasma HDL-C levels, we identified a homozygote for a loss-of-function variant, in which leucine replaces proline 376 (P376L), in SCARB1, the gene encoding SR-BI. The P376L variant impairs posttranslational processing of SR-BI and abrogates selective HDL cholesterol uptake in transfected cells, in hepatocyte-like cells derived from induced pluripotent stem cells from the homozygous subject, and in mice. Large population-based studies revealed that subjects who are heterozygous carriers of the P376L variant have significantly increased levels of plasma HDL-C. P376L carriers have a profound HDL-related phenotype and an increased risk of CHD (odds ratio = 1.79, which is statistically significant).Entities:
Mesh:
Substances:
Year: 2016 PMID: 26965621 PMCID: PMC4889017 DOI: 10.1126/science.aad3517
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728